Beersheba, Israel

Yuri Futerman

This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2007.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yuri Futerman

Introduction

Yuri Futerman is a notable inventor based in Beersheba, IL. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on halobetasol propionate. His expertise and dedication to research have led to the development of unique crystalline forms of this compound.

Latest Patents

Yuri Futerman holds 1 patent for his invention titled "Crystalline forms of halobetasol propionate." This patent provides a detailed description of various crystalline forms of halobetasol propionate, each characterized by specific power X-ray diffraction peak positions and intensities. The invention includes crystalline Forms I through VI, each with distinct properties that enhance the understanding and application of halobetasol propionate in medical treatments.

Career Highlights

Futerman's career is marked by his role at Chemagis Ltd., where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the company's portfolio but has also impacted the broader field of dermatological treatments. His innovative approach and thorough research methodologies have established him as a respected figure in his industry.

Collaborations

Yuri has collaborated with talented individuals such as Ori Lerman and Alexander Weisman. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the pharmaceutical sector.

Conclusion

Yuri Futerman's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his importance as an inventor. His work continues to influence the development of effective medical treatments, showcasing the impact of dedicated research and innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…